Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials
Given the continuous emergence of hepatitis and the associated consequences, developing effective antiviral strategies has become a major public health concern.Current antiviral strategies for the treatment of hepatitis, especially for hepatitis B virus (HBV) and hepatitis C skittles ornament virus (HCV), and those under discovery and development a